Theriva Biologics, Inc. · CIK 894158
Theriva Biologics, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
1
Original notices
1
Amendments
0
Activity
Oct 24, 2025
through Oct 24, 2025
through Oct 24, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $13,109,494
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $13,109,494
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Same reported sales compensation recipient
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- ADIAL PHARMACEUTICALS, INC. · CIK 1513525
- Century Lithium Corp. · CIK 1394039
- CNS Pharmaceuticals, Inc. · CIK 1729427
- CYABRA, INC. · CIK 2032341
- Evogene Ltd. · CIK 1574565
Form D filings (1)
-
0001104659-25-101914D · Oct 24, 2025 · BiotechnologyOffering: $13,109,494Sold: $13,109,494